Zydus Lifesciences Limited — Important, 25-04-2025: General Updates

Zydus Lifesciences Limited has signed a share purchase agreement to acquire a controlling stake of 85.6% in Amplitude Surgical SA for Euro 256.8 million at Euro 6.25 per share. This acquisition includes a previous put option agreement and agreements with two minority shareholders. Following the acquisition, Zydus plans to initiate a mandatory simplified cash tender offer for the remaining shares, also at Euro 6.25 per share, leading to a potential compulsory acquisition of minority shares if conditions are met.

The completion of the acquisition is expected by Q3 2025, pending standard closing conditions, including approvals from relevant authorities and the absence of adverse events. Notably, Zydus has commitments to tender an additional 4.7% of shares, potentially raising their stake above 90% after the tender offer. This strategic acquisition positions Zydus for enhanced growth in the medical devices sector, warranting close observation for its implications on future revenues and market presence.